Abstract
Interferon (IFN)-beta therapy has well-established clinical benefits in multiple sclerosis (MS), but the underlying modulation of cytokine responses to myelin self-antigens remains poorly understood. We analysed the CD4+ T cell proliferation and cytokine responses elicited by myelin basic protein (MBP) and a foreign recall antigen, tetanus toxoid (TT), in mononuclear cell cultures from fourteen MS patients undergoing IFN-beta therapy. The MBP-elicited IFN-gamma-, TNF-alpha- and IL-10 production decreased during therapy (p
Original language | English |
---|---|
Journal | Clinical Immunology |
Volume | 129 |
Issue number | 1 |
Pages (from-to) | 80-9 |
Number of pages | 10 |
ISSN | 1521-6616 |
DOIs | |
Publication status | Published - 1 Oct 2008 |